CRON
Price
$2.04
Change
+$0.04 (+2.00%)
Updated
Jul 3 closing price
Capitalization
1B
32 days until earnings call
OGI
Price
$1.43
Change
+$0.05 (+3.62%)
Updated
Jul 3 closing price
Capitalization
200.85M
Interact to see
Advertisement

CRON vs OGI

Header iconCRON vs OGI Comparison
Open Charts CRON vs OGIBanner chart's image
Cronos Group
Price$2.04
Change+$0.04 (+2.00%)
Volume$1.94M
Capitalization1B
Organigram Global
Price$1.43
Change+$0.05 (+3.62%)
Volume$546.1K
Capitalization200.85M
CRON vs OGI Comparison Chart in %
Loading...
CRON
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
OGI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CRON vs. OGI commentary
Jul 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CRON is a Hold and OGI is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 06, 2025
Stock price -- (CRON: $2.04 vs. OGI: $1.43)
Brand notoriety: CRON and OGI are both not notable
Both companies represent the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: CRON: 114% vs. OGI: 97%
Market capitalization -- CRON: $1B vs. OGI: $200.85M
CRON [@Pharmaceuticals: Other] is valued at $1B. OGI’s [@Pharmaceuticals: Other] market capitalization is $200.85M. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $77.48B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $3.8B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CRON’s FA Score shows that 0 FA rating(s) are green whileOGI’s FA Score has 0 green FA rating(s).

  • CRON’s FA Score: 0 green, 5 red.
  • OGI’s FA Score: 0 green, 5 red.
According to our system of comparison, OGI is a better buy in the long-term than CRON.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CRON’s TA Score shows that 4 TA indicator(s) are bullish while OGI’s TA Score has 3 bullish TA indicator(s).

  • CRON’s TA Score: 4 bullish, 6 bearish.
  • OGI’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, both CRON and OGI are a bad buy in the short-term.

Price Growth

CRON (@Pharmaceuticals: Other) experienced а +6.81% price change this week, while OGI (@Pharmaceuticals: Other) price change was +2.14% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +2.13%. For the same industry, the average monthly price growth was +3.08%, and the average quarterly price growth was +93.03%.

Reported Earning Dates

CRON is expected to report earnings on Nov 05, 2025.

OGI is expected to report earnings on May 12, 2025.

Industries' Descriptions

@Pharmaceuticals: Other (+2.13% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CRON($1.01B) has a higher market cap than OGI($201M). CRON YTD gains are higher at: 0.990 vs. OGI (-11.180). CRON has higher annual earnings (EBITDA): -71.8M vs. OGI (-195.74M). CRON has more cash in the bank: 862M vs. OGI (42.3M). OGI has less debt than CRON: OGI (136K) vs CRON (2.55M). OGI has higher revenues than CRON: OGI (161M) vs CRON (87.2M).
CRONOGICRON / OGI
Capitalization1.01B201M500%
EBITDA-71.8M-195.74M37%
Gain YTD0.990-11.180-9%
P/E RatioN/AN/A-
Revenue87.2M161M54%
Total Cash862M42.3M2,038%
Total Debt2.55M136K1,877%
FUNDAMENTALS RATINGS
CRON vs OGI: Fundamental Ratings
CRON
OGI
OUTLOOK RATING
1..100
5050
VALUATION
overvalued / fair valued / undervalued
1..100
56
Fair valued
51
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
8482
PRICE GROWTH RATING
1..100
5347
P/E GROWTH RATING
1..100
7939
SEASONALITY SCORE
1..100
n/a50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

OGI's Valuation (51) in the null industry is in the same range as CRON (56) in the Pharmaceuticals Other industry. This means that OGI’s stock grew similarly to CRON’s over the last 12 months.

OGI's Profit vs Risk Rating (100) in the null industry is in the same range as CRON (100) in the Pharmaceuticals Other industry. This means that OGI’s stock grew similarly to CRON’s over the last 12 months.

OGI's SMR Rating (82) in the null industry is in the same range as CRON (84) in the Pharmaceuticals Other industry. This means that OGI’s stock grew similarly to CRON’s over the last 12 months.

OGI's Price Growth Rating (47) in the null industry is in the same range as CRON (53) in the Pharmaceuticals Other industry. This means that OGI’s stock grew similarly to CRON’s over the last 12 months.

OGI's P/E Growth Rating (39) in the null industry is somewhat better than the same rating for CRON (79) in the Pharmaceuticals Other industry. This means that OGI’s stock grew somewhat faster than CRON’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
CRONOGI
RSI
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 4 days ago
83%
Stochastic
ODDS (%)
Bearish Trend 4 days ago
85%
Bearish Trend 4 days ago
90%
Momentum
ODDS (%)
Bullish Trend 4 days ago
69%
Bullish Trend 4 days ago
86%
MACD
ODDS (%)
Bullish Trend 4 days ago
78%
Bearish Trend 4 days ago
90%
TrendWeek
ODDS (%)
Bullish Trend 4 days ago
75%
Bullish Trend 4 days ago
83%
TrendMonth
ODDS (%)
Bullish Trend 4 days ago
75%
Bullish Trend 4 days ago
81%
Advances
ODDS (%)
Bullish Trend 4 days ago
69%
Bullish Trend 4 days ago
84%
Declines
ODDS (%)
Bearish Trend 27 days ago
84%
Bearish Trend 14 days ago
85%
BollingerBands
ODDS (%)
Bearish Trend 4 days ago
82%
Bearish Trend 4 days ago
90%
Aroon
ODDS (%)
Bearish Trend 4 days ago
84%
Bullish Trend 4 days ago
78%
View a ticker or compare two or three
Interact to see
Advertisement
CRON
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
OGI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
BMSSX14.880.12
+0.81%
MFS Blended Research Mid Cap Eq R2
EIEMX16.090.11
+0.69%
Parametric Emerging Markets I
AMRGX7.160.04
+0.56%
American Growth One D
ITCSX30.140.13
+0.43%
VY® T. Rowe Price Capital Apprec S
PPYPX8.77-0.02
-0.23%
PIMCO RAE International I-2

OGI and

Correlation & Price change

A.I.dvisor indicates that over the last year, OGI has been closely correlated with SNDL. These tickers have moved in lockstep 67% of the time. This A.I.-generated data suggests there is a high statistical probability that if OGI jumps, then SNDL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To OGI
1D Price
Change %
OGI100%
+3.62%
SNDL - OGI
67%
Closely correlated
+1.60%
TLRY - OGI
61%
Loosely correlated
+11.03%
ACB - OGI
60%
Loosely correlated
+1.57%
CRON - OGI
59%
Loosely correlated
+2.00%
CGC - OGI
59%
Loosely correlated
+7.56%
More